Latest Influenza vaccine Stories
Chris Behling, President of Mollen was elected Treasurer of the Care Continuum Alliance during the annual membership meeting which closed the CCA’s Forum 12 in Atlanta, Georgia. Scottsdale, AZ (PRWEB) October 23, 2012 Chris Behling, President of Mollen was elected Treasurer of the Care Continuum Alliance during the annual membership meeting which closed the CCA’s Forum 12 in Atlanta, Georgia. “CCA members and the PHM industry are fortunate to have leaders such as Chris Behling,”...
NES ZIONA, Israel, October 22, 2012 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (TASE: BNDX) today announced that the Company has passed successfully a 2 day QP GMP audit during which the Company`s manufacturing facility, production process, personnel and quality control procedures were examined in great detail. This demanding certification is a requirement for Companies intending to manufacture a clinical grade product for human trials anywhere in Europe and gives the...
SWIFTWATER, Pa., Oct. 22, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented today an overview of Phase II and Phase III clinical trials for its investigational quadrivalent influenza vaccine (QIV). Three clinical trials have been conducted to evaluate the safety and the immune response to the quadrivalent influenza vaccine in children, adults and the elderly. All three studies demonstrated that the safety and immunogenicity...
SWIFTWATER, Pa., Oct. 18, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for a quadrivalent formulation of its Fluzone(® ) (Influenza Virus Vaccine). The sBLA file has been accepted by the FDA for full review, and an action date is anticipated in the second quarter of 2013. "The...
ALBANY, New York, October 16, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Global Pneumococcal Vaccine Market 2011-2015 [http://www.researchmoz.us/global-pneumococcal-vaccine-market-2011-2015-report.html ] TechNavio [http://www.researchmoz.us/publisher/technavio-73.html ]'s analysts forecast the Global Pneumococcal Vaccine market [http://www.researchmoz.us/global-pneumococcal-vaccine-market-2011-2015-report.html ] to grow at a CAGR of 18...
OAKLAND, Calif., Oct. 15, 2012 /PRNewswire/ -- Tracy A. Lieu, MD, MPH, director of the Division of Research, Kaiser Permanente Northern California, has been elected to the Institute of Medicine effective Oct. 1, 2012. The IOM, the health arm of the National Academy of Sciences, works outside of government to provide unbiased and authoritative advice to decision-makers and the public. Many of the studies that the IOM undertakes begin as specific mandates from Congress; others are...
WOONSOCKET, R.I., Oct. 11, 2012 /PRNewswire/ -- Despite recommendations from the Center for Disease Control and Prevention (CDC) that everyone 6 months or older get a flu vaccine every year, just over half (51%) of the respondents to a consumer survey conducted by CVS/pharmacy say they do not plan to get a flu shot this season. The top reasons consumers cite in the survey for not getting vaccinated are being worried about potential side effects of a flu shot and not being sure...
CAMBRIDGE, Mass., Oct. 10, 2012 /PRNewswire/ -- Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $30 million in a Series C financing round. The Bill & Melinda Gates Foundation and CVF, LLC, an affiliate of Henry Crown and Company, are participating alongside all of Genocea's existing investors, including Polaris Venture Partners, Lux Capital, SR One, Johnson & Johnson Development Corporation, Skyline...
A new model of influenza transmission, published in BioMed Central's open access journal BMC Medicine, using more detailed information about patterns and severity of infection than previous models, finds that cases and transmission rates of H1N1 during the 2009-2010 flu pandemic have been underestimated. This model can provide a more robust and accurate real-time estimate of infection during a pandemic, which will help health services prepare and respond to future outbreaks. During an...
CHICAGO, Oct. 9, 2012 /PRNewswire/ -- To help improve flu immunization rates in underserved communities, Walgreens (NYSE, NASDAQ: WAG) and Access Community Health Network (ACCESS) are again working together to provide greater access to flu vaccines this season. Through this collaboration, Walgreens is providing 5,000 free flu shot vouchers to ACCESS to help those without health insurance coverage and those unable to afford a flu shot without the voucher. This effort will also help...
